@inproceedings{oai:repo.qst.go.jp:00074666,
 author = {片桐, 健 and 稲庭, 拓 and 岩田, 佳之 and 早乙女, 直也 and 佐藤, 眞二 and 皿谷, 有一 and 高田, 栄一 and 丹正, 亮平 and 野田, 悦夫 and 原, 洋介 and 古川, 卓司 and 村松, 正幸 and 水島, 康太 and 白井, 敏之 and 鈴木, 太久(AEC) and 高橋, 勝之(AEC) and 川島, 祐洋(AEC) and 勝間, 田匡(AEC) and 小林, 千広(AEC) and 若勇, 充司(AEC) and Katagiri, Ken and Inaniwa, Taku and Iwata, Yoshiyuki and Saotome, Naoya and Sato, Shinji and Saraya, Yuichi and Takada, Eiichi and Tansho, Ryohei and Noda, Etsuo and Hara, Yousuke and Furukawa, Takuji and Muramatsu, Masayuki and Mizushima, Kota and Shirai, Toshiyuki},
 book = {2018年第15回日本加速器学会年会プロシーディングス},
 month = {Oct},
 note = {Heavy ion cancer therapy with the Heavy ion Medical Accelerator synchrotron in Chiba (HIMAC) has been administered to more than 10,000 patients since 1994. We started the heavy-ion cancer therapy using a 3D scanning irradiation
system in May 2011, at New Particle Therapy Research Facility in NIRS. To enhance the treatment quality by achieving a precise dose control, we have continued some R&Ds on HIMAC and its irradiation system including a superconductingrotating gantry. Since 2016, we have started developments of a compact superconducting rotating gantry and a compact superconducting synchrotron to be applied for a newly started project of a “quantum scalpel” that is a next generation of the heavy-ion cancer therapy machine. We also started R&Ds for the intensity modulated multi-ion therapy that is applied to improve outcomes of the refractory cancer treatment. This paper outlines those R&Ds as well as the present status of HIMAC accelerator facility.},
 pages = {1355--1358},
 title = {HIMAC加速器の現状報告(2018)},
 year = {2018}
}